Yahav Achim Ve Achayot - Provident Funds Management Company’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-20,570
| Closed | -$2.03M | – | 23 |
|
2024
Q3 | $2.03M | Hold |
20,570
| – | – | 5.47% | 6 |
|
2024
Q2 | $1.91M | Hold |
20,570
| – | – | 3.51% | 10 |
|
2024
Q1 | $1.95M | Hold |
20,570
| – | – | 3.09% | 8 |
|
2023
Q4 | $1.84M | Hold |
20,570
| – | – | 1.54% | 14 |
|
2023
Q3 | $1.53M | Hold |
20,570
| – | – | 1.32% | 16 |
|
2023
Q2 | $1.71M | Hold |
20,570
| – | – | 1.31% | 17 |
|
2023
Q1 | $1.54M | Hold |
20,570
| – | – | 1.51% | 20 |
|
2022
Q4 | $1.7M | Hold |
20,570
| – | – | 1.61% | 17 |
|
2022
Q3 | $1.62M | Hold |
20,570
| – | – | 1.57% | 19 |
|
2022
Q2 | $1.52M | Hold |
20,570
| – | – | 1.36% | 22 |
|
2022
Q1 | $1.84M | Hold |
20,570
| – | – | 1.41% | 20 |
|
2021
Q4 | $2.33M | Hold |
20,570
| – | – | 1.68% | 20 |
|
2021
Q3 | $2.59M | Buy |
+20,570
| New | +$2.59M | 2.03% | 19 |
|